US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist

2.9200
-0.0300-1.02%

Close Nov 29 13:00 ET

2.9200
0.00000.00%

Post 17:01 ET

26.95MMarket Cap-463P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-21.75%-6.29M

-57.53%-7.72M

-569.48%-10.75M

-7.08%-25.12M

-764.73%-13.45M

34.74%-5.17M

-10.14%-4.9M

83.16%-1.61M

-1,280.73%-23.46M

68.12%-1.56M

Net income from continuing operations

-102.84%-10.35M

-6.61%-7.34M

31.66%-5.03M

-125.14%-42.19M

-190.26%-22.86M

27.89%-5.1M

-44.07%-6.88M

-845.93%-7.35M

-9.31%-18.74M

31.83%-7.87M

Operating gains losses

96.84%-6.17K

-720.10%-2.22M

-6,521.24%-5.47M

146.74%4.87M

13,183.43%4.79M

75.08%-195.47K

120.66%357.52K

98.95%-82.59K

-399.28%-10.42M

-100.88%-36.6K

Depreciation and amortization

-1.89%966.86K

18.27%1.06M

114.99%1.98M

13.77%3.75M

2.26%944.4K

8.30%985.45K

14.25%892.27K

36.27%923.17K

99.07%3.29M

39.68%923.52K

Other non cash items

---48.36K

-270.80%-85.4K

-189.80%-83.99K

11,623.32%3.71M

--3.57M

--0

--50K

--93.53K

---32.21K

----

Change In working capital

240.24%2.1M

609.17%263.34K

-165.88%-2.77M

1,079.15%2.33M

-108.84%-427.41K

3.33%-1.49M

-94.75%37.13K

199.44%4.21M

-102.03%-237.58K

299.83%4.84M

-Change in receivables

-64.65%127.88K

-107.90%-31.69K

-104.03%-193.23K

126.42%5.56M

--0

110.86%361.74K

-81.53%401.39K

226.95%4.79M

-80.46%2.45M

235.32%7.39M

-Change in prepaid assets

-111.21%-25.84K

103.06%687.93K

-190.79%-289.54K

-177.62%-523.61K

-155.56%-1.41M

-74.44%230.56K

-50.14%338.79K

189.93%318.9K

153.61%674.55K

65.25%-552.46K

-Change in payables and accrued expense

309.99%1.99M

86.03%-111.71K

66.30%-1.34M

-33.04%-4.42M

161.02%1.3M

-203.00%-947.76K

62.41%-799.85K

-29,207.33%-3.97M

-843.79%-3.32M

-445.79%-2.13M

-Change in other current assets

-96.89%3.99K

-112.79%-18.06K

-108.29%-10.4K

624.72%387.3K

-105.88%-7.56K

426.64%128.11K

885.63%141.22K

794.31%125.53K

183.99%53.44K

828.78%128.72K

-Change in other working capital

--0

-492.42%-263.14K

-132.14%-944.58K

1,422.41%1.32M

---305.01K

---1.27M

---44.42K

3,039.20%2.94M

---100K

--0

Cash from discontinued investing activities

Operating cash flow

-21.75%-6.29M

-57.53%-7.72M

-569.48%-10.75M

-7.08%-25.12M

-764.73%-13.45M

34.74%-5.17M

-10.14%-4.9M

83.16%-1.61M

-1,280.73%-23.46M

68.12%-1.56M

Investing cash flow

Cash flow from continuing investing activities

-2,721.23%-1.15M

49,556.96%11.22M

-147,126.32%-31.36M

92.69%-152.7K

42.37%-67.86K

47.96%-40.86K

96.30%-22.68K

98.34%-21.3K

80.90%-2.09M

95.01%-117.75K

Net PPE purchase and sale

-145.50%-100.3K

-131.49%-52.51K

-505.98%-129.07K

92.69%-152.7K

42.37%-67.86K

47.96%-40.86K

96.30%-22.68K

98.34%-21.3K

80.90%-2.09M

95.01%-117.75K

Net investment purchase and sale

---1.05M

--11.27M

---31.23M

----

--0

----

Cash from discontinued investing activities

Investing cash flow

-2,721.23%-1.15M

49,556.96%11.22M

-147,126.32%-31.36M

92.69%-152.7K

42.37%-67.86K

47.96%-40.86K

96.30%-22.68K

98.34%-21.3K

80.90%-2.09M

95.01%-117.75K

Financing cash flow

Cash flow from continuing financing activities

-380.46%-674.13K

11.75%-321.04K

-9.62%-394.42K

6,250.81%66.77M

706.40%67.64M

51.13%-140.31K

50.24%-363.79K

94.31%-359.79K

-97.07%1.05M

-76.72%8.39M

Net issuance payments of debt

-354.77%-649.13K

30.64%-252.33K

31.59%-247.44K

67.05%-390.45K

-32.39%477.76K

50.28%-142.74K

54.54%-363.79K

55.04%-361.68K

-176.73%-1.19M

-58.12%706.69K

Net common stock issuance

----

--0

----

--2.16M

--7.68M

Net preferred stock issuance

----

--7.5M

----

--0

----

Proceeds from stock option exercised by employees

--0

980.00%20.41K

77,414.37%59.66M

5,965,926,300.00%59.66M

242,900.00%2.43K

--0

-75.86%1.89K

1,040.31%76.97K

-100.01%-1

Net other financing activities

---25K

---68.71K

---167.39K

----

Cash from discontinued financing activities

Financing cash flow

-380.46%-674.13K

11.75%-321.04K

-9.62%-394.42K

6,250.81%66.77M

706.40%67.64M

51.13%-140.31K

50.24%-363.79K

94.31%-359.79K

-97.07%1.05M

-76.72%8.39M

Net cash flow

Beginning cash position

121.78%17.24M

7.46%14.03M

275.93%56.57M

-61.95%15.05M

-70.89%2.43M

-53.21%7.77M

-41.72%13.06M

-61.95%15.05M

213.59%39.55M

-22.50%8.33M

Current changes in cash

-51.78%-8.12M

160.16%3.18M

-2,039.29%-42.5M

269.40%41.5M

706.03%54.12M

35.43%-5.35M

8.74%-5.29M

88.41%-1.99M

-190.95%-24.5M

-76.68%6.71M

Effect of exchange rate changes

--47.54K

--28.28K

---28.27K

--18.14K

--0

----

End cash Position

278.12%9.17M

121.78%17.24M

7.46%14.03M

275.93%56.57M

-70.89%2.43M

-53.21%7.77M

-41.72%13.06M

-61.95%15.05M

Free cash flow

-21.69%-6.39M

-57.87%-7.77M

-568.65%-10.88M

1.21%-25.32M

-707.91%-13.51M

34.31%-5.25M

2.75%-4.92M

85.07%-1.63M

-186.11%-25.63M

76.90%-1.67M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-21.75%-6.29M	-57.53%-7.72M	-569.48%-10.75M	-7.08%-25.12M	-764.73%-13.45M	34.74%-5.17M	-10.14%-4.9M	83.16%-1.61M	-1,280.73%-23.46M	68.12%-1.56M
Net income from continuing operations	-102.84%-10.35M	-6.61%-7.34M	31.66%-5.03M	-125.14%-42.19M	-190.26%-22.86M	27.89%-5.1M	-44.07%-6.88M	-845.93%-7.35M	-9.31%-18.74M	31.83%-7.87M
Operating gains losses	96.84%-6.17K	-720.10%-2.22M	-6,521.24%-5.47M	146.74%4.87M	13,183.43%4.79M	75.08%-195.47K	120.66%357.52K	98.95%-82.59K	-399.28%-10.42M	-100.88%-36.6K
Depreciation and amortization	-1.89%966.86K	18.27%1.06M	114.99%1.98M	13.77%3.75M	2.26%944.4K	8.30%985.45K	14.25%892.27K	36.27%923.17K	99.07%3.29M	39.68%923.52K
Other non cash items	---48.36K	-270.80%-85.4K	-189.80%-83.99K	11,623.32%3.71M	--3.57M	--0	--50K	--93.53K	---32.21K	----
Change In working capital	240.24%2.1M	609.17%263.34K	-165.88%-2.77M	1,079.15%2.33M	-108.84%-427.41K	3.33%-1.49M	-94.75%37.13K	199.44%4.21M	-102.03%-237.58K	299.83%4.84M
-Change in receivables	-64.65%127.88K	-107.90%-31.69K	-104.03%-193.23K	126.42%5.56M	--0	110.86%361.74K	-81.53%401.39K	226.95%4.79M	-80.46%2.45M	235.32%7.39M
-Change in prepaid assets	-111.21%-25.84K	103.06%687.93K	-190.79%-289.54K	-177.62%-523.61K	-155.56%-1.41M	-74.44%230.56K	-50.14%338.79K	189.93%318.9K	153.61%674.55K	65.25%-552.46K
-Change in payables and accrued expense	309.99%1.99M	86.03%-111.71K	66.30%-1.34M	-33.04%-4.42M	161.02%1.3M	-203.00%-947.76K	62.41%-799.85K	-29,207.33%-3.97M	-843.79%-3.32M	-445.79%-2.13M
-Change in other current assets	-96.89%3.99K	-112.79%-18.06K	-108.29%-10.4K	624.72%387.3K	-105.88%-7.56K	426.64%128.11K	885.63%141.22K	794.31%125.53K	183.99%53.44K	828.78%128.72K
-Change in other working capital	--0	-492.42%-263.14K	-132.14%-944.58K	1,422.41%1.32M	---305.01K	---1.27M	---44.42K	3,039.20%2.94M	---100K	--0
Cash from discontinued investing activities
Operating cash flow	-21.75%-6.29M	-57.53%-7.72M	-569.48%-10.75M	-7.08%-25.12M	-764.73%-13.45M	34.74%-5.17M	-10.14%-4.9M	83.16%-1.61M	-1,280.73%-23.46M	68.12%-1.56M
Investing cash flow
Cash flow from continuing investing activities	-2,721.23%-1.15M	49,556.96%11.22M	-147,126.32%-31.36M	92.69%-152.7K	42.37%-67.86K	47.96%-40.86K	96.30%-22.68K	98.34%-21.3K	80.90%-2.09M	95.01%-117.75K
Net PPE purchase and sale	-145.50%-100.3K	-131.49%-52.51K	-505.98%-129.07K	92.69%-152.7K	42.37%-67.86K	47.96%-40.86K	96.30%-22.68K	98.34%-21.3K	80.90%-2.09M	95.01%-117.75K
Net investment purchase and sale	---1.05M	--11.27M	---31.23M	----	----	--0	--0	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-2,721.23%-1.15M	49,556.96%11.22M	-147,126.32%-31.36M	92.69%-152.7K	42.37%-67.86K	47.96%-40.86K	96.30%-22.68K	98.34%-21.3K	80.90%-2.09M	95.01%-117.75K
Financing cash flow
Cash flow from continuing financing activities	-380.46%-674.13K	11.75%-321.04K	-9.62%-394.42K	6,250.81%66.77M	706.40%67.64M	51.13%-140.31K	50.24%-363.79K	94.31%-359.79K	-97.07%1.05M	-76.72%8.39M
Net issuance payments of debt	-354.77%-649.13K	30.64%-252.33K	31.59%-247.44K	67.05%-390.45K	-32.39%477.76K	50.28%-142.74K	54.54%-363.79K	55.04%-361.68K	-176.73%-1.19M	-58.12%706.69K
Net common stock issuance	----	----	----	--0	----	----	----	----	--2.16M	--7.68M
Net preferred stock issuance	----	----	----	--7.5M	----	----	----	----	--0	----
Proceeds from stock option exercised by employees	--0	--0	980.00%20.41K	77,414.37%59.66M	5,965,926,300.00%59.66M	242,900.00%2.43K	--0	-75.86%1.89K	1,040.31%76.97K	-100.01%-1
Net other financing activities	---25K	---68.71K	---167.39K	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-380.46%-674.13K	11.75%-321.04K	-9.62%-394.42K	6,250.81%66.77M	706.40%67.64M	51.13%-140.31K	50.24%-363.79K	94.31%-359.79K	-97.07%1.05M	-76.72%8.39M
Net cash flow
Beginning cash position	121.78%17.24M	7.46%14.03M	275.93%56.57M	-61.95%15.05M	-70.89%2.43M	-53.21%7.77M	-41.72%13.06M	-61.95%15.05M	213.59%39.55M	-22.50%8.33M
Current changes in cash	-51.78%-8.12M	160.16%3.18M	-2,039.29%-42.5M	269.40%41.5M	706.03%54.12M	35.43%-5.35M	8.74%-5.29M	88.41%-1.99M	-190.95%-24.5M	-76.68%6.71M
Effect of exchange rate changes	--47.54K	--28.28K	---28.27K	--18.14K	--18.14K	--0	--0	--0	--0	----
End cash Position	278.12%9.17M	121.78%17.24M	7.46%14.03M	275.93%56.57M	275.93%56.57M	-70.89%2.43M	-53.21%7.77M	-41.72%13.06M	-61.95%15.05M	-61.95%15.05M
Free cash flow	-21.69%-6.39M	-57.87%-7.77M	-568.65%-10.88M	1.21%-25.32M	-707.91%-13.51M	34.31%-5.25M	2.75%-4.92M	85.07%-1.63M	-186.11%-25.63M	76.90%-1.67M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data